壊死性皮膚感染症治療の世界市場（～2026年）

• 英文タイトル：Global Necrotizing Skin infections Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY03923
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は壊死性皮膚感染症治療のグローバル市場について調査・分析したレポートです。種類別（手術、抗生物質）市場規模、用途別（病院、診療所、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別壊死性皮膚感染症治療の競争状況、市場シェア
・世界の壊死性皮膚感染症治療市場：種類別市場規模 2015年-2020年（手術、抗生物質）
・世界の壊死性皮膚感染症治療市場：種類別市場規模予測 2021年-2026年（手術、抗生物質）
・世界の壊死性皮膚感染症治療市場：用途別市場規模 2015年-2020年（病院、診療所、外来手術センター、その他）
・世界の壊死性皮膚感染症治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、外来手術センター、その他）
・北米の壊死性皮膚感染症治療市場分析：米国、カナダ
・ヨーロッパの壊死性皮膚感染症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの壊死性皮膚感染症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の壊死性皮膚感染症治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの壊死性皮膚感染症治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Actavis (Durata Therapeutics)、Merck (Cubist Pharmaceutical)、Wockhardt、Atox Bio、Basilea Pharmaceutical、Melinta Therapeutics
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Necrotizing skin infections ranks among the most rarely found diseases but are highly lethal infection. Necrotizing skin infection arise primarily in any layer of skin soft tissue such as dermis and epidermis that are associated with necrotizing changes. Necrotizing skin infection is also commonly called as “Flesh eating disease”. Necrotizing skin infections penetrates deeper layers of soft tissues and rapidly spreads along facial planes.
The global market for necrotizing skin infection treatment is expected to register a moderate growth rate over the forecast period on the account of increase in number of diagnostic tests performed in humans.

Market Analysis and Insights: Global Necrotizing Skin infections Treatment Market
The global Necrotizing Skin infections Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Necrotizing Skin infections Treatment Scope and Market Size
Necrotizing Skin infections Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Necrotizing Skin infections Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Actavis (Durata Therapeutics)
Merck (Cubist Pharmaceutical)
Wockhardt
Atox Bio
Basilea Pharmaceutical
Melinta Therapeutics
…

Market segment by Type, the product can be split into
Surgery
Antibiotics
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgery Centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Necrotizing Skin infections Treatment Revenue
1.4 Market by Type
1.4.1 Global Necrotizing Skin infections Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Antibiotics
1.5 Market by Application
1.5.1 Global Necrotizing Skin infections Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgery Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Necrotizing Skin infections Treatment Market Perspective (2015-2026)
2.2 Global Necrotizing Skin infections Treatment Growth Trends by Regions
2.2.1 Necrotizing Skin infections Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Necrotizing Skin infections Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Necrotizing Skin infections Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Necrotizing Skin infections Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Necrotizing Skin infections Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Necrotizing Skin infections Treatment Players by Market Size
3.1.1 Global Top Necrotizing Skin infections Treatment Players by Revenue (2015-2020)
3.1.2 Global Necrotizing Skin infections Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Necrotizing Skin infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Necrotizing Skin infections Treatment Market Concentration Ratio
3.2.1 Global Necrotizing Skin infections Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Necrotizing Skin infections Treatment Revenue in 2019
3.3 Necrotizing Skin infections Treatment Key Players Head office and Area Served
3.4 Key Players Necrotizing Skin infections Treatment Product Solution and Service
3.5 Date of Enter into Necrotizing Skin infections Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Necrotizing Skin infections Treatment Historic Market Size by Type (2015-2020)
4.2 Global Necrotizing Skin infections Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Necrotizing Skin infections Treatment Market Size by Application (2015-2020)
5.2 Global Necrotizing Skin infections Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Necrotizing Skin infections Treatment Market Size (2015-2020)
6.2 Necrotizing Skin infections Treatment Key Players in North America (2019-2020)
6.3 North America Necrotizing Skin infections Treatment Market Size by Type (2015-2020)
6.4 North America Necrotizing Skin infections Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Necrotizing Skin infections Treatment Market Size (2015-2020)
7.2 Necrotizing Skin infections Treatment Key Players in Europe (2019-2020)
7.3 Europe Necrotizing Skin infections Treatment Market Size by Type (2015-2020)
7.4 Europe Necrotizing Skin infections Treatment Market Size by Application (2015-2020)

8 China
8.1 China Necrotizing Skin infections Treatment Market Size (2015-2020)
8.2 Necrotizing Skin infections Treatment Key Players in China (2019-2020)
8.3 China Necrotizing Skin infections Treatment Market Size by Type (2015-2020)
8.4 China Necrotizing Skin infections Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Necrotizing Skin infections Treatment Market Size (2015-2020)
9.2 Necrotizing Skin infections Treatment Key Players in Japan (2019-2020)
9.3 Japan Necrotizing Skin infections Treatment Market Size by Type (2015-2020)
9.4 Japan Necrotizing Skin infections Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Necrotizing Skin infections Treatment Market Size (2015-2020)
10.2 Necrotizing Skin infections Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Necrotizing Skin infections Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Necrotizing Skin infections Treatment Market Size by Application (2015-2020)

11 India
11.1 India Necrotizing Skin infections Treatment Market Size (2015-2020)
11.2 Necrotizing Skin infections Treatment Key Players in India (2019-2020)
11.3 India Necrotizing Skin infections Treatment Market Size by Type (2015-2020)
11.4 India Necrotizing Skin infections Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Necrotizing Skin infections Treatment Market Size (2015-2020)
12.2 Necrotizing Skin infections Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Necrotizing Skin infections Treatment Market Size by Type (2015-2020)
12.4 Central & South America Necrotizing Skin infections Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Actavis (Durata Therapeutics)
13.1.1 Actavis (Durata Therapeutics) Company Details
13.1.2 Actavis (Durata Therapeutics) Business Overview
13.1.3 Actavis (Durata Therapeutics) Necrotizing Skin infections Treatment Introduction
13.1.4 Actavis (Durata Therapeutics) Revenue in Necrotizing Skin infections Treatment Business (2015-2020))
13.1.5 Actavis (Durata Therapeutics) Recent Development
13.2 Merck (Cubist Pharmaceutical)
13.2.1 Merck (Cubist Pharmaceutical) Company Details
13.2.2 Merck (Cubist Pharmaceutical) Business Overview
13.2.3 Merck (Cubist Pharmaceutical) Necrotizing Skin infections Treatment Introduction
13.2.4 Merck (Cubist Pharmaceutical) Revenue in Necrotizing Skin infections Treatment Business (2015-2020)
13.2.5 Merck (Cubist Pharmaceutical) Recent Development
13.3 Wockhardt
13.3.1 Wockhardt Company Details
13.3.2 Wockhardt Business Overview
13.3.3 Wockhardt Necrotizing Skin infections Treatment Introduction
13.3.4 Wockhardt Revenue in Necrotizing Skin infections Treatment Business (2015-2020)
13.3.5 Wockhardt Recent Development
13.4 Atox Bio
13.4.1 Atox Bio Company Details
13.4.2 Atox Bio Business Overview
13.4.3 Atox Bio Necrotizing Skin infections Treatment Introduction
13.4.4 Atox Bio Revenue in Necrotizing Skin infections Treatment Business (2015-2020)
13.4.5 Atox Bio Recent Development
13.5 Basilea Pharmaceutical
13.5.1 Basilea Pharmaceutical Company Details
13.5.2 Basilea Pharmaceutical Business Overview
13.5.3 Basilea Pharmaceutical Necrotizing Skin infections Treatment Introduction
13.5.4 Basilea Pharmaceutical Revenue in Necrotizing Skin infections Treatment Business (2015-2020)
13.5.5 Basilea Pharmaceutical Recent Development
13.6 Melinta Therapeutics
13.6.1 Melinta Therapeutics Company Details
13.6.2 Melinta Therapeutics Business Overview
13.6.3 Melinta Therapeutics Necrotizing Skin infections Treatment Introduction
13.6.4 Melinta Therapeutics Revenue in Necrotizing Skin infections Treatment Business (2015-2020)
13.6.5 Melinta Therapeutics Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Necrotizing Skin infections Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Necrotizing Skin infections Treatment Revenue
Table 3. Ranking of Global Top Necrotizing Skin infections Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Necrotizing Skin infections Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery
Table 6. Key Players of Antibiotics
Table 7. Global Necrotizing Skin infections Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Necrotizing Skin infections Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Necrotizing Skin infections Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Necrotizing Skin infections Treatment Market Share by Regions (2015-2020)
Table 11. Global Necrotizing Skin infections Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Necrotizing Skin infections Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Necrotizing Skin infections Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Necrotizing Skin infections Treatment Players
Table 18. Global Necrotizing Skin infections Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Necrotizing Skin infections Treatment Market Share by Players (2015-2020)
Table 20. Global Top Necrotizing Skin infections Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Necrotizing Skin infections Treatment as of 2019)
Table 21. Global Necrotizing Skin infections Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Necrotizing Skin infections Treatment Product Solution and Service
Table 24. Date of Enter into Necrotizing Skin infections Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Necrotizing Skin infections Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Necrotizing Skin infections Treatment Market Size Share by Type (2015-2020)
Table 28. Global Necrotizing Skin infections Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Necrotizing Skin infections Treatment Market Size Share by Application (2015-2020)
Table 30. Global Necrotizing Skin infections Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Necrotizing Skin infections Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Necrotizing Skin infections Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Necrotizing Skin infections Treatment Market Share (2019-2020)
Table 34. North America Necrotizing Skin infections Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Necrotizing Skin infections Treatment Market Share by Type (2015-2020)
Table 36. North America Necrotizing Skin infections Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Necrotizing Skin infections Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Necrotizing Skin infections Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Necrotizing Skin infections Treatment Market Share (2019-2020)
Table 40. Europe Necrotizing Skin infections Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Necrotizing Skin infections Treatment Market Share by Type (2015-2020)
Table 42. Europe Necrotizing Skin infections Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Necrotizing Skin infections Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Necrotizing Skin infections Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Necrotizing Skin infections Treatment Market Share (2019-2020)
Table 46. China Necrotizing Skin infections Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Necrotizing Skin infections Treatment Market Share by Type (2015-2020)
Table 48. China Necrotizing Skin infections Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Necrotizing Skin infections Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Necrotizing Skin infections Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Necrotizing Skin infections Treatment Market Share (2019-2020)
Table 52. Japan Necrotizing Skin infections Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Necrotizing Skin infections Treatment Market Share by Type (2015-2020)
Table 54. Japan Necrotizing Skin infections Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Necrotizing Skin infections Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Necrotizing Skin infections Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Necrotizing Skin infections Treatment Market Share (2019-2020)
Table 58. Southeast Asia Necrotizing Skin infections Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Necrotizing Skin infections Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Necrotizing Skin infections Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Necrotizing Skin infections Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Necrotizing Skin infections Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Necrotizing Skin infections Treatment Market Share (2019-2020)
Table 64. India Necrotizing Skin infections Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Necrotizing Skin infections Treatment Market Share by Type (2015-2020)
Table 66. India Necrotizing Skin infections Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Necrotizing Skin infections Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Necrotizing Skin infections Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Necrotizing Skin infections Treatment Market Share (2019-2020)
Table 70. Central & South America Necrotizing Skin infections Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Necrotizing Skin infections Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Necrotizing Skin infections Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Necrotizing Skin infections Treatment Market Share by Application (2015-2020)
Table 74. Actavis (Durata Therapeutics) Company Details
Table 75. Actavis (Durata Therapeutics) Business Overview
Table 76. Actavis (Durata Therapeutics) Product
Table 77. Actavis (Durata Therapeutics) Revenue in Necrotizing Skin infections Treatment Business (2015-2020) (Million US$)
Table 78. Actavis (Durata Therapeutics) Recent Development
Table 79. Merck (Cubist Pharmaceutical) Company Details
Table 80. Merck (Cubist Pharmaceutical) Business Overview
Table 81. Merck (Cubist Pharmaceutical) Product
Table 82. Merck (Cubist Pharmaceutical) Revenue in Necrotizing Skin infections Treatment Business (2015-2020) (Million US$)
Table 83. Merck (Cubist Pharmaceutical) Recent Development
Table 84. Wockhardt Company Details
Table 85. Wockhardt Business Overview
Table 86. Wockhardt Product
Table 87. Wockhardt Revenue in Necrotizing Skin infections Treatment Business (2015-2020) (Million US$)
Table 88. Wockhardt Recent Development
Table 89. Atox Bio Company Details
Table 90. Atox Bio Business Overview
Table 91. Atox Bio Product
Table 92. Atox Bio Revenue in Necrotizing Skin infections Treatment Business (2015-2020) (Million US$)
Table 93. Atox Bio Recent Development
Table 94. Basilea Pharmaceutical Company Details
Table 95. Basilea Pharmaceutical Business Overview
Table 96. Basilea Pharmaceutical Product
Table 97. Basilea Pharmaceutical Revenue in Necrotizing Skin infections Treatment Business (2015-2020) (Million US$)
Table 98. Basilea Pharmaceutical Recent Development
Table 99. Melinta Therapeutics Company Details
Table 100. Melinta Therapeutics Business Overview
Table 101. Melinta Therapeutics Product
Table 102. Melinta Therapeutics Revenue in Necrotizing Skin infections Treatment Business (2015-2020) (Million US$)
Table 103. Melinta Therapeutics Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Necrotizing Skin infections Treatment Market Share by Type: 2020 VS 2026
Figure 2. Surgery Features
Figure 3. Antibiotics Features
Figure 4. Global Necrotizing Skin infections Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Ambulatory Surgery Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Necrotizing Skin infections Treatment Report Years Considered
Figure 10. Global Necrotizing Skin infections Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Necrotizing Skin infections Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Necrotizing Skin infections Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Necrotizing Skin infections Treatment Market Share by Players in 2019
Figure 15. Global Top Necrotizing Skin infections Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Necrotizing Skin infections Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Necrotizing Skin infections Treatment Revenue in 2019
Figure 17. North America Necrotizing Skin infections Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Necrotizing Skin infections Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Necrotizing Skin infections Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Necrotizing Skin infections Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Necrotizing Skin infections Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Necrotizing Skin infections Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Necrotizing Skin infections Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

以下、関連資料のご紹介

壊死性筋膜炎の世界市場（～2026年）

Global Necrotizing Fasciitis Market Size, Status and Forecast 2020-2026
MRC2-11QY03922 2020年11月20日 97Pages
当調査資料は壊死性筋膜炎のグローバル市場について調査・分析したレポートです。種類別（静脈内抗生物質、手術、高圧酸素治療）市場規模、用途別（病院＆クリニック、外科センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、...

人工関節感染症治療の世界市場（～2026年）

Global Prosthetic Joint Infections Treatment Market Insights and Forecast to 2026
MRC2-11QY14436 2020年11月30日 114Pages
当調査資料は人工関節感染症治療のグローバル市場について調査・分析したレポートです。種類別（フシジン酸、酢酸レファムリン、MTF-101、TNP-2092、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、ア...

エプスタインバーウイルス（HHV-4）感染症治療の世界市場（～2026年）

Global Epstein-Barr Virus (HHV-4) Infections Treatment Market Insights and Forecast to 2026
MRC2-11QY05775 2020年11月20日 118Pages
当調査資料はエプスタインバーウイルス（HHV-4）感染症治療のグローバル市場について調査・分析したレポートです。種類別（メシル酸アパチニブ、AR-12、バルタリューセル-T、その他）市場規模、用途別（病院、クリニック、ASC、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス...

目感染症治療の世界市場（～2026年）

Global Eye Infections Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11908 2020年11月25日 129Pages
当調査資料は目感染症治療のグローバル市場について調査・分析したレポートです。種類別（ジェル・クリーム、点眼薬、薬剤）市場規模、用途別（眼科クリニック、病院、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓...

非黒色腫皮膚がん治療の世界市場（～2026年）

Global Non-Melanoma Skin Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04008 2020年11月20日 132Pages
当調査資料は非黒色腫皮膚がん治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、光線力学療法）市場規模、用途別（病院、診療所、外来外科センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

皮膚がん診断・治療の世界市場（～2026年）

Global Skin Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04630 2020年11月20日 133Pages
当調査資料は皮膚がん診断・治療のグローバル市場について調査・分析したレポートです。種類別（化学線ケラトーゼ（AK）、ベース細胞癌（BCC）、扁平上皮癌（SCC）、メラノーマ）市場規模、用途別（病院、がん研究センター、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギ...

ナイセリア淋菌感染症治療の世界市場（～2026年）

Global Neisseria Gonorrhoeae Infections Treatment Market Insights and Forecast to 2026
MRC2-11QY08098 2020年11月20日 112Pages
当調査資料はナイセリア淋菌感染症治療のグローバル市場について調査・分析したレポートです。種類別（クリブロスタチン-6、ダルババンシン、デビオ-1453、メシル酸ゲポチダシン、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリ...

ライノウイルス感染症治療薬の世界市場（～2026年）

Global Rhinovirus Infections Drug Market Insights and Forecast to 2026
MRC2-11QY09118 2020年11月25日 119Pages
当調査資料はライノウイルス感染症治療薬のグローバル市場について調査・分析したレポートです。種類別（塩化セチルピリジニウム、ヒトライノウイルス（多価）ワクチン、KR-22809、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギ...

A型インフルエンザウイルス・H3N2亜型感染症薬の世界市場（～2026年）

Global Influenza A Virus, H3N2 Subtype Infections Drug Market Insights and Forecast to 2026
MRC2-11QY01676 2020年11月20日 150Pages
当調査資料はA型インフルエンザウイルス・H3N2亜型感染症薬のグローバル市場について調査・分析したレポートです。種類別（NEO-8877、NP-025、NSC-61610、NVINF-1、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フ...

皮膚がん治療薬の世界市場（～2026年）

Global Skin Cancer Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04632 2020年11月20日 95Pages
当調査資料は皮膚がん治療薬のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、凍結手術、免疫療法、光線力学療法、手術、その他の治療）市場規模、用途別（病院、診療所、がん研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イ...

壊死性筋膜炎の世界市場（～2026年） Necrotizing fasciitis (NF), commonly known as flesh-eating disease, is an infection that results in the death of the body's soft tissue. It is a severe disease of sudden onset that spreads rapidly. Symptoms include red or purple skin in the affected area, severe pain, fever, and vomiting. The most c…
目感染症治療の世界市場（～2026年） Eye infections can be the inflammation of the Conjunctiva (Conjunctivitis), eyelid (blepharitis), the cornea (keratitis), the liquid inside the eye (vitritis), the retina and the blood vessels that feed it (chorioretinitis), or the optic nerve (neuroretinitis). Eye infections treatment market is gro…
人工関節感染症治療の世界市場（～2026年） Market Analysis and Insights: Global Prosthetic Joint Infections Treatment Market The global Prosthetic Joint Infections Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prosthetic Joint Infections Treatment S…
ナイセリア淋菌感染症治療の世界市場（～2026年） Market Analysis and Insights: Global Neisseria Gonorrhoeae Infections Treatment Market The global Neisseria Gonorrhoeae Infections Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Neisseria Gonorrhoeae Infecti…
エプスタインバーウイルス（HHV-4）感染症治療の世界市場（～2026年） Market Analysis and Insights: Global Epstein-Barr Virus (HHV-4) Infections Treatment Market The global Epstein-Barr Virus (HHV-4) Infections Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Epstein-Barr Virus …